5-Lipoxygenase expression and activity in aorta from streptozotocin-induced diabetic rats

Prostaglandins and Other Lipid Mediators

Volumn 75, Issue 1-4, 2005, Pages 91-103

  Hardy, G ^a   Vergnaud, S ^b   Lunardi, J ^b   Peoc'h, M ^b   Bessard, G ^a   Stanke Labesque, F ^a  

^a University Grenoble Alpes   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

5 Lipoxygenase; Diabetes; Leukotrienes; Rat aorta; Smooth muscle cells

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; CALCIMYCIN; PEPTIDOLEUKOTRIENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOZOCIN DIABETES; WESTERN BLOTTING;

EID: 13844275022     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2004.10.002     Document Type: Article

References (39)

1. C.A. Rouzer, and S. Kargman Translocation of 5-lipoxygenase to the membrane in human leukocytes challenged with ionophore A23187 J Biol Chem 263 1988 10980
2. R.A. Dixon, R.E. Diehl, and E. Opas Requirement of a 5-lipoxygenase- activating protein for leukotriene synthesis Nature 343 1990 282
3. M. Peters-Golden, and T.G. Brock Intracellular compartmentalization of leukotriene synthesis: unexpected nuclear secrets FEBS Lett 487 2001 323
4. G. Folco, G. Rossoni, C. Buccellati, F. Berti, J. Maclouf, and A. Sala Leukotrienes in cardiovascular diseases Am J Respir Crit Care Med 161 2000 112
5. 4 induced vascular smooth muscle cell proliferation: a possible role in myointimal hyperplasia Thromb Haemost 76 1996 99
6. 4 in coronary artery disease and after coronary artery bypass surgery Coron Artery Dis 4 1993 899
7. J.H. Dwyer, H. Allayee, and K.M. Dwyer Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis N Engl J Med 350 2004 29
8. M. Carry, V. Korley, J.T. Willerson, L. Weigelt, A.W. Ford-Hutchinson, and P. Tagari Increased urinary leukotriene excretion in patients with cardiac ischemia. In vivo evidence for 5-lipoxygenase activation Circulation 85 1992 230
9. F. Stanke-Labesque, P. Devillier, S. Veitl, F. Caron, J.L. Cracowski, and G. Bessard Cysteinyl leukotrienes are involved in angiotensin II-induced contraction of aorta from spontaneously hypertensive rats Cardiovasc Res 49 2001 152
10. F. Stanke-Labesque, G. Hardy, and S. Vergnaud Involvement of cysteinyl leukotrienes in angiotensin II-induced contraction in isolated aortas from transgenic (mRen-2)27 rats J Hypertens 20 2002 263
11. G. Hardy, F. Stanke-Labesque, and M. Peoc'h Cysteinyl leukotrienes modulate angiotensin II constrictor effects on aortas from streptozotocin- induced diabetic rats Arterioscler Thromb Vasc Biol 21 2001 1751
12. A. Helgadottir, A. Manolescu, and G. Thorleifsson The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke Nat Genet 36 2004 233
13. 4 release in people with diabetes mellitus Diabetes Res Clin Pract 46 1999 43
14. J.M. Valdivielso, A. Montero, K.F. Badr, and K.A. Munger Inhibition of 5-lipoxygenase activating protein decreases proteinuria in diabetic rats J Nephrol 16 2003 85
15. B. Samuelsson Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation Science 220 1983 568
16. A.W. Ford-Hutchinson, M. Gresser, and R.N. Young 5-Lipoxygenase Ann Rev Biochem 63 1994 383
17. J. Larrue, M. Rigaud, G. Razaka, D. Daret, J. Demond-Henri, and H. Bricaud Formation of monohydroxyeicosatetraenoic acids from arachidonic acid by cultured rabbit aortic smooth muscle cells Biochem Biophys Res Commun 112 1983 242
18. B.O. Ibe, and J.U. Raj Leukotriene metabolism by intrapulmonary vessels of newborn lambs: effect of platelet-activating factor Exp Lung Res 27 2001 331
19. J. Kahler, A. Conforto, R. Dudek, A. Termin, and R.J. Bing Synthesis of leukotrienes by freshly harvested endothelial cells J Mol Cell Cardiol 25 1993 647
20. Y.Y. Zhang, J.L. Walker, and A. Huang Expression of 5-lipoxygenase in pulmonary artery endothelial cells Biochem J 361 2002 267
21. M. Luchtefeld, H. Drexler, and B. Schieffer 5-Lipoxygenase is involved in the angiotensin II-induced NAD(P)H-oxidase activation Biochem Biophys Res Commun 308 2003 668
22. M.J. Garcia, P.M. McNamara, T. Gordon, and W.B. Kannel Morbidity and mortality in diabetics in the Framingham population. Sixteen-year follow-up study Diabetes 23 1974 105
23. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 1976 248
24. S. Vergnaud, M.H. Paclet, J. El Benna, M.A. Pocidalo, and F. Morel Complementation of NADPH oxidase in p67-phox-deficient CGD patients p67-phox/p40-phox interaction Eur J Biochem 267 2000 1059
25. P. Chomczynski, and N. Sacchi Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal Biochem 162 1987 156
26. T. Uz, P. Longone, and H. Manev Increased hippocampal 5-lipoxygenase mRNA content in melatonin-deficient, pinealectomized rats J Neurochem 69 1997 2220
27. R. Natarajan, J.L. Gu, and J. Rossi Elevated glucose and angiotensin II increase 12-lipoxygenase activity and expression in porcine aortic smooth muscle cells Proc Natl Acad Sci USA 90 1993 4947
28. C.A. Rouzer, A.W. Ford-Hutchinson, H.E. Morton, and J.W. Gillard MK886, a potent and specific leukotriene biosynthesis inhibitor blocks and reverses the membrane association of 5-lipoxygenase in ionophore-challenged leukocytes J Biol Chem 265 1990 1436
29. B.O. Ibe, J.M. Anderson, and J.U. Raj Leukotriene synthesis by isolated perinatal ovine intrapulmonary vessels correlates with age-related changes in 5-lipoxygenase protein Biochem Mol Med 61 1997 63
30. S. Allen, M. Dashwood, K. Morrison, and M. Yacoub Differential leukotriene constrictor responses in human atherosclerotic coronary arteries Circulation 97 1998 2406
31. J.M. Balcarek, T.W. Theisen, and M.N. Cook Isolation and characterization of a cDNA clone encoding rat 5-lipoxygenase J Biol Chem 263 1988 13937
32. N.F. Voelkel, R.M. Tuder, and K. Wade Inhibition of 5-lipoxygenase- activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats J Clin Invest 97 1996 2491
33. O.F. Cole, T.P. Fan, and G.P. Lewis Release of eicosanoids from cultured rat aortic endothelial cells; studies with arachidonic acid and calcium ionophore A23187 Cell Biol Int Rep 10 1986 407
34. D.M. Roth, D.K. Reibel, and A.M. Lefer Altered coronary vascular responsiveness to leukotrienes in alloxan-diabetic rats Circ Res 54 1984 388
35. 4 on cavian pulmonary artery and aorta. Characterization and mechanisms Ann NY Acad Sci 524 1988 91
36. 4: importance of the magnitude of preload Eicosanoids 2 1989 175
37. T. Kobayashi, and K. Kamata Effect of chronic insulin treatment on NO production and endothelium-dependent relaxation in aortae from established STZ-induced diabetic rats Atherosclerosis 155 2001 313
38. T. Kobayashi, and K. Kamata Effect of insulin treatment on smooth muscle contractility and endothelium-dependent relaxation in rat aortae from established STZ-induced diabetes Br J Pharmacol 127 1999 835
39. I. Antonipillai, J. Nadler, E.J. Vu, S. Bughi, R. Natarajan, and R. Horton A 12-lipoxygenase product, 12-hydroxyeicosatetraenoic acid, is increased in diabetics with incipient and early renal disease J Clin Endocrinol Metab 81 1996 1940